Satellos Bioscience Inc. Opens the Market

TORONTO, May 15, 2024 /PRNewswire/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani Lipkin, Managin

PR NewswireMay 15 11:04 ET

Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders

Stockhouse May 14 17:05 ET

Satellos Bioscience Q1 Loss Widens Due To Higher Expenses; But Says "On Track" to Initiate Phase 1 First-in-human Clinical Trials Mid-2024

Satellos Bioscience Inc. (MSCL.TO), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, earlier on Tuesday reported

MT NewswiresMay 14 11:01 ET

Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Stockhouse Apr 8 07:00 ET

Stocks in Play: Satellos Bioscience Inc.

Baystreet.caMar 27 11:10 ET

Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights

Stockhouse Mar 27 07:00 ET